Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. - Wikidata - awgldk - TriplyDB

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

http://www.wikidata.org/entity/Q46944917

about

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.Germline mutations and polymorphisms in the origins of cancers in women.Single-nucleotide polymorphisms in the p53 signaling pathway.MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group.Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis.Deficiency of a potential 3p21.3 tumor suppressor gene UBE1L (UBA7) does not accelerate lung cancer development in K-rasLA2 mice.A functional variant of IC53 correlates with the late onset of colorectal cancer.TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.Haplotype structure and selection of the MDM2 oncogene in humans.Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer.Ubiquitin ligases in cancer: ushers for degradation.MDM2 expression and regulation in prostate cancer racial disparity Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk.Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene.Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.MDM2 SNP309 is associated with endometrial cancer risk.Ubiquitin at the crossroad of cell death and survival.Molecular mechanisms involving prostate cancer racial disparity.Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung.Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls.MDM2 SNP309 polymorphism is associated with colorectal cancer risk.MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.miR deregulation in CLL.The Role of MDM2 Amplification and Overexpression in Tumorigenesis.MDM2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients.Molecular basis for prostate cancer racial disparities.Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells.MDM2 SNP309 accelerates colorectal tumour formation in women.MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients.MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.

P2860

Q33373153-04398F15-B785-4FED-8DA2-A84037E8ABB0 Q33606675-F385AA33-E3FD-4C98-A268-1409AD84B7A0 Q33800384-8CE7BB35-E1AC-4552-98CB-406DC817A2EB Q33914462-AABAE0EF-5BBB-4215-BE86-D039336629EB Q34043467-00D22241-8241-4A4B-BD7E-6AE75FC1318C Q34134333-F404E6B0-8128-4DD4-861D-875D6FDE7B6E Q34148472-CB1816DB-5618-44D6-99EA-F7739A808974 Q34968358-016CF639-2C4D-4B90-BC02-74CCB0FC6504 Q35010195-53894280-1B80-4A31-906B-25D89C68781D Q35025532-92F23F6F-A7E4-494A-929E-A28701094CA8 Q35108242-23345F31-CCBB-4735-8B72-9686AC88B4A0 Q35136758-20BA3FDA-C14B-4DBC-98DA-DF617DF3A421 Q35206102-F510B8D8-7722-4BA9-9584-FDDAAF2522BF Q35240086-AC3FB0D1-D160-423E-AA7D-737A46429DD8 Q35721519-23D8383B-3E1A-477E-B213-98E43B24F3FC Q35897781-3230C288-D5FC-4B1A-BA61-1501E0CF1A2F Q35906322-6B0A1420-5D62-457D-8514-D20BBAC92D2A Q36594047-4782792E-BDC9-4DF7-B145-D7E5768D3C26 Q36614777-4DD6F99A-9717-436C-9C5C-145116E69F3D Q36946774-3DF1A775-11FC-4B68-B2C8-A86501BCC9BD Q37041767-19271444-7B7C-49EF-B7EA-31F72A4B94C5 Q37228792-FA38EBCE-9E72-4D89-A154-30680148ED0A Q37238851-F385AB9C-BDA0-419E-886F-67DFDA1EB311 Q37293815-473D7C70-53CA-4191-8CF7-A8B804AF3179 Q37309516-54A938CA-3868-4323-AD5A-E899B9AD7265 Q37409763-2FDE35E0-7243-4FD8-9CB4-D39DA77B70C8 Q37418937-D6CDE0AB-367D-4C95-A7E5-9206265FCF8C Q37703388-ADDCC7D7-7F9B-49A1-8C33-7FE4266A8F56 Q37722658-4441B2E7-4ED2-4240-8687-26F52C3D10C5 Q37738261-FFC844F3-704C-46AB-ABF3-4B1B70BD3DC8 Q37872630-572C4852-BC11-4461-A9C0-E71E5F30E059 Q38021448-14507399-2E9B-49D3-8C4D-11A8AEC4645D Q38135352-7E12DA19-DD17-453C-82D0-9155A0A18F02 Q38837916-55F8709C-DF16-4465-AF9C-16D92CD356F8 Q40382596-4D2AC23C-78DD-4662-9E95-16ACA2EC0FE4 Q41334556-DFDF71AC-DB96-4B07-89FD-A9980A522941 Q42720958-C83D6274-68B5-4364-AFE3-E8B5E47945BF Q43146294-8964305F-A509-4689-8201-06F125E91B70 Q44248155-103BED8D-C93B-43EE-BE0A-0154A9C47BDC Q44745420-06D4216B-8166-45B1-AFF2-6181D39E1A25

P2860

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

http://www.wikidata.org/entity/Q46944917

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Association between MDM2-SNP30 ...... ording to p53 mutation status.

@en

Association between MDM2-SNP30 ...... ording to p53 mutation status.

@nl

type

label

Association between MDM2-SNP30 ...... ording to p53 mutation status.

@en

Association between MDM2-SNP30 ...... ording to p53 mutation status.

@nl

prefLabel

Association between MDM2-SNP30 ...... ording to p53 mutation status.

@en

Association between MDM2-SNP30 ...... ording to p53 mutation status.

@nl

P1433

Q46944917-E14C3B95-6475-47C5-ABD9-85415284EF64

P1476

Q46944917-C041CA70-B1AA-43E8-8645-958304C98497

P2093

Q46944917-26CC3E82-E6D1-4CC8-894B-465B3C5305B3

Q46944917-46A39ABD-FB7E-4E8E-BB1D-6AAA6E643965

Q46944917-5693CF36-2BE6-411D-8527-F8451A7620C6

Q46944917-7C18C09E-A1BF-421A-BC45-46729C4B4F17

Q46944917-9B429A29-E751-4D9F-BA50-CA6A03AF0AC0

Q46944917-B982B24B-5EF4-48AC-9674-9EA16A29F19E

Q46944917-CC72201C-03CE-4498-80D6-160A72E0C102

Q46944917-E11432A5-CE93-4F9F-8901-147863D7FF64

Q46944917-E60D845A-57B9-40C7-BA46-953EDB4D33BE

P2860

Q46944917-194AC43D-8D7A-4503-AF46-E26ECE4147FB

Q46944917-2F688835-9257-40C1-B6F3-E2B07D869885

Q46944917-56CFADF9-A78B-4774-8CBF-ACAE0D1A1FF2

Q46944917-7022A796-7155-48AA-B2CB-AA64A729B9A8

Q46944917-9064771F-ABDD-410D-8E5B-FC8C5F0E20DB

Q46944917-D2B57ADB-9136-4FDD-9A14-7584B9AC50E6

Q46944917-E74A3FA6-0789-4C09-8843-8FB3118228BD

Q46944917-E97E88F0-6206-4A59-80E3-59A3411BD19F

P304

Q46944917-CE24F9DF-6D77-4ACA-8E03-6A3AD5F8A572

P31

Q46944917-E6611A48-5BC6-47F0-B4E4-B1A6A28E1896

P356

Q46944917-66683EDF-50EE-4C80-B25C-E4829A5AE225

P407

Q46944917-B52C0705-156C-440E-9D83-952D0DEF0C33

P433

Q46944917-3DBA2EEA-0FA5-417D-A723-4E07DB21C1F4

P478

Q46944917-01F87E6D-B86E-439F-91A6-0E217A8BA76A

P50

Q46944917-39A3C460-21FA-42CF-8E8B-DAC8D7CBA5CB

Q46944917-5DFD00FB-B26E-46E7-880A-A501153E6B41

Q46944917-EA0DB07D-A915-4D4A-A8F6-E168A4644B14

Q46944917-F6C876F8-B4D4-4102-B79A-86A3E34B1891

P577

Q46944917-0379B10B-5D52-4377-967A-C826A276AFC0

P5875

Q46944917-C9B8AB67-9CBB-4411-AA01-D74CF5236582

P698

Q46944917-63B92A85-A53F-4F00-9AE1-8220FBB222C3

P921

Q46944917-94FA5EF0-E490-44D1-9F42-C224F973678A

P356

P1433

Journal of the National Cancer Institute

P1476

Association between MDM2-SNP30 ...... cording to p53 mutation status

@en

P2093

Alberto Amadori

http://www.w3.org/2001/XMLSchema#string

Donato Nitti

http://www.w3.org/2001/XMLSchema#string

Emma D'Andrea

http://www.w3.org/2001/XMLSchema#string

Giovanni Esposito

http://www.w3.org/2001/XMLSchema#string

Marco Montagna

http://www.w3.org/2001/XMLSchema#string

Martina Biscuola

http://www.w3.org/2001/XMLSchema#string

Monica Quaggio

http://www.w3.org/2001/XMLSchema#string

Roberta Bertorelle

http://www.w3.org/2001/XMLSchema#string

Simona Agata

http://www.w3.org/2001/XMLSchema#string

P2860

Surfing the p53 network

Polymorphisms and colorectal tumor risk.

The MDM2 gene amplification database

The p53-Mdm2 module and the ubiquitin system.

Genetic predisposition to colorectal cancer.

A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells.

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li – Fraumeni patients carrying a mutation to the TP53 gene

P304

285-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJJ054

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Claudio Belluco

Gian Luca De Salvo

Maria Chiara Scaini

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7297756

http://www.w3.org/2001/XMLSchema#string

P698

16478747

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer